[ad_1]
Northwell Health has signed a memorandum of understanding with Enterprise Singapore, a government agency that supports the growth of Singaporean companies and their expansion into international markets.
The agreement creates a formal framework for Singapore-based biomedical firms to engage with Northwell, the largest health system in New York State and among the largest in the U.S. The collaboration is intended to promote innovation in precision medicine, digital health, clinical trials and healthcare operations, with the broader goal of enhancing patient care on a global scale.
“Northwell is committed to building bridges with international partners that can bring transformative solutions to our patients and communities,” Michael Dowling, president and CEO of Northwell Health, said in a news release about the agreement.
“Our collaboration with Enterprise Singapore provides an opportunity to connect with some of the most innovative companies in Singapore and accelerate the adoption of new technologies that will shape the future of healthcare,” Dowling said.
The agreement follows a year of collaboration between Northwell Health’s Global Strategic Partnerships program and Enterprise Singapore as well as Singapore-based companies.
Enterprise Singapore supports Singapore’s biomedical innovation sector by helping companies build capabilities, access funding and form international partnerships.
“Enterprise Singapore is excited to create new opportunities for collaboration between Singapore biomedical companies and leading health care systems like Northwell Health in the U.S.,” Lee Chuan Teck, chairman of Enterprise Singapore, said in the news release.
“Together with Northwell Health, we are building pathways to accelerate medical innovations, strengthen US-Singapore partnerships and improve healthcare for people in both countries,” Teck said.
[ad_2]
Adina Genn
Source link